View clinical trials related to Pharmacokinetic.
Filter by:A double-blind, randomised, placebo-controlled, single-ascending and multiple-ascending dose trial to evaluate the safety and pharmacokinetics of oral controlled-ileal-release nicotinic acid (CIR-NA) compared to immediate-release nicotinic acid and placebo in healthy subjects and subjects with prediabetes.
This is an open-label pharmacokinetic study in 16 healthy Thai subjects. To assess the safety and tolerability and pharmacological interactions of the combination of artemether-lumefantrine and amodiaquine. This study is funded by Prof White's WT PRF. The Welcome Trust grant reference number is B9R04920.
To study the single dose and multi-doses pharmacokinetic characteristics and tolerance of TQ-A3326 in the human body;To study the transformation of TQ-A3326;To study the effect of the food on the pharmacokinetic characteristics of TQ-A3326.